Stocks Health care YBGJ
OTC · Health careYubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd brought in $12.4K of revenue over the twelve months to June 30, 2026. It posted a net loss of $933.8K. At June 30, 2026 it held $12K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch YBGJ in 60 secondsWhat Yubo International Biotech Ltd does
Yubo International Biotech Ltd is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker YBGJ.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $12.4K | -$1.1M | -$0.01 | n/a |
| 2024 | $3.5K | -$1.8M | -$0.02 | n/a |
| 2023 | $604.7K | -$1.2M | -$0.10 | n/a |
| 2022 | $104.3K | -$1.2M | n/a | -$601K |
| 2021 | $1.2M | -$1.5M | n/a | -$1.6M |
| 2020 | n/a | -$711.8K | n/a | $58.6K |
Full financial statements: income, balance sheet and cash flow
Where YBGJ ranks in Health care
Latest SEC filings
What Yubo International Biotech Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026
- June 12, 2026
- June 12, 2026Form DEF 14C filing DEF 14C
- May 15, 2026
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue rose 256% to $12.4K versus the prior year; diluted EPS -$0.01 versus -$0.02.
- January 16, 2026Auditor change 8-K
- November 14, 2025
- August 13, 2025
- July 25, 2025Activist stake changed SCHEDULE 13D/A
- July 25, 2025Activist stake changed SCHEDULE 13D/A
Who owns YBGJ
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Flydragon International Ltd13D, may seek influence with 1 related filers | 48.1% | July 25, 2025 |
| Boao Biotech Ltd13G, passive with 1 related filers | 16.6% | June 3, 2025 |
| Chinaone Technology Ltd13D, may seek influence with 1 related filers | 15.1% | July 25, 2025 |
Largest institutional holders
Insiders
Questions about YBGJ
What does Yubo International Biotech Ltd do?
Yubo International Biotech Ltd is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker YBGJ.
Is Yubo International Biotech Ltd profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $933.8K on revenue of $12.4K.
How much revenue does Yubo International Biotech Ltd make?
Over the twelve months to June 30, 2026 Yubo International Biotech Ltd reported revenue of $12.4K.
When did Yubo International Biotech Ltd last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare YBGJ with
Follow YBGJ
Get an email when Yubo International Biotech Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Follow YBGJ: get an email when it filesWhere the numbers come from
Financial figures are the values Yubo International Biotech Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.